Corient Private Wealth
OLMA icon

Corient Private Wealth’s Olema Pharmaceuticals OLMA Stock Holding History

Corient Private Wealth’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$566K Buy
+37,994
New +$846K ﹤0.01% 1963
2025
Q4 		– Sell
-10,299
Closed -$101K – 2805
2025
Q3 		$101K Buy
+10,299
New +$61.8K ﹤0.01% 2444

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Corient Private Wealth's OLMA Position: Q1 2026 in Review

Corient Private Wealth opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 37,994 shares worth $566K. The stake represents ﹤0.01% of the portfolio and ranks #1963 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in OLMA as recently as Q3 2025.

Corient Private Wealth first reported a position in OLMA in Q3 2025 and has held it in 2 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Corient Private Wealth held 37,994 shares of Olema Pharmaceuticals worth $566K as of Q1 2026.
  • Olema Pharmaceuticals was a new Corient Private Wealth position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1963 holding.
  • Corient Private Wealth first reported a position in Olema Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.